Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review

被引:64
|
作者
Gerestein, Cornelis G. [1 ,3 ]
Damhuis, Ronald A. M. [2 ]
Burger, Curt W. [3 ]
Kooi, Geertruida S. [1 ]
机构
[1] Albert Schweitzer Hosp, Dept Obstet & Gynecol, Dordrecht, Netherlands
[2] Rotterdam Canc Registry, Rotterdam, Netherlands
[3] Univ Med Ctr, Daniel Den Hoed Erasmus MC, Dept Obstet & Gynecol, Div Gynecol Oncol, Rotterdam, Netherlands
关键词
Postoperative mortality; 30-day mortality; Ovarian cancer; Primary cytoreductive surgery; Advanced stage; PRIMARY PERITONEAL CANCER; NEOADJUVANT CHEMOTHERAPY; SURGICAL CYTOREDUCTION; GYNECOLOGIC ONCOLOGISTS; PRIMARY DEBULKING; BOWEL RESECTION; FALLOPIAN-TUBE; ELDERLY-WOMEN; CARCINOMA; SURVIVAL;
D O I
10.1016/j.ygyno.2009.03.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Accurate estimation of the risk of postoperative mortality (POM) is essential for the decision whether or not to perform cytoreductive surgery in a patient with advanced stage ovarian cancer. To ascertain modern reference figures, a systematic review of studies reporting POM after primary cytoreductive surgery for advanced stage epithelial ovarian cancer (EOC) was performed. Materials and methods. A Medline search was performed to retrieve papers on primary cytoreductive surgery for advanced stage EOC. Twenty-three papers met the inclusion criteria and were reviewed. Results. According to population-based studies, POM after primary cytoreductive surgery for EOC is 3.7% on average. Single centre studies report an average rate of 2.5%. The overall mean POM is 2.8%. POM is more frequent for elderly women and after extensive procedures. Accurate information on age-specific and procedure-specific rates could not be obtained. Conclusion. POM rates after surgery for EOC are satisfactorily low. There is a clear need for reliable reference figures for mortality after debulking surgery in the elderly. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:523 / 527
页数:5
相关论文
共 50 条
  • [1] SPLENECTOMY AS PRIMARY CYTOREDUCTIVE SURGERY IN ADVANCED STAGE EPITHELIAL OVARIAN CANCER
    Akilli, H.
    Karakas, L. Aksoy
    Nihan, H.
    Ayhan, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A429 - A430
  • [2] Cytoreductive surgery in primary advanced epithelial ovarian cancer
    Luca Ansaloni
    Federico Coccolini
    Fausto Catena
    Luigi Frigerio
    Robert E Bristow
    World Journal of Obstetrics and Gynecology, 2013, (04) : 116 - 123
  • [3] 30-day mortality following primary cytoreductive surgery for advanced stage epithelial ovarian cancer in the elderly
    Thrall, M.
    Goff, B.
    Symons, R.
    Flum, D.
    Gray, H.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 437 - 437
  • [4] The role of cytoreductive surgery in advanced-stage ovarian cancer: A systematic review
    Vitale S.G.
    Marilli I.
    Lodato M.
    Tropea A.
    Cianci A.
    Updates in Surgery, 2013, 65 (4) : 265 - 270
  • [5] Age-related risk of postoperative mortality after cytoreductive surgery for advanced ovarian cancer
    Bercow, A.
    Melamed, A.
    Eisenhauer, E. L.
    Rauh-Hain, J. A.
    Wright, J. D.
    Rice, L. W.
    del Carmen, M. G.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 263 - 263
  • [6] EXTENSIVE PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED EPITHELIAL OVARIAN-CANCER
    GUIDOZZI, F
    BALL, JHS
    GYNECOLOGIC ONCOLOGY, 1994, 53 (03) : 326 - 330
  • [7] Thirty-Day Mortality After Primary Cytoreductive Surgery for Advanced Ovarian Cancer in the Elderly
    Thrall, Melissa M.
    Goff, Barbara A.
    Symons, Rebecca Gaston
    Flum, David R.
    Gray, Heidi J.
    OBSTETRICS AND GYNECOLOGY, 2011, 118 (03): : 537 - 547
  • [8] Current Status of Primary Cytoreductive Surgery for the Treatment of Advanced Epithelial Ovarian Cancer
    Nasu, Kaei
    Matsumoto, Harunobu
    Takai, Noriyuki
    Narahara, Hisashi
    CURRENT CANCER THERAPY REVIEWS, 2009, 5 (01) : 67 - 79
  • [9] Peak postoperative glucose levels predict complications after primary cytoreductive surgery for advanced ovarian cancer
    Axtell, A. E.
    Berry, E.
    Schink, J.
    Holschneider, C. H.
    Walsh, C.
    Cass, I.
    Karlan, B. Y.
    Li, A. J.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S40 - S40
  • [10] Peak postoperative glucose levels predict complications after primary cytoreductive surgery for advanced ovarian cancer
    Axtell, A. E.
    Holschneider, C. H.
    Cass, I.
    Walsh, C. S.
    Leuchter, R. S.
    Karlan, B. Y.
    Li, A. J.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 378 - 378